- Recent Funding
- Investors
- Intermediate Capital Group
Intermediate Capital Group portfolio
Intermediate Capital Group has 2 portfolio companies on record at Recent Funding. It is a private equity firm based in London, GB, founded in 1989. Its most recent investment on record is Draig Therapeutics's $140M Seed round in June 2025, which it led, alongside SV Health Investors. By category, its portfolio leans toward Health and bio (2).
About Intermediate Capital Group
The companies Intermediate Capital Group bought, as a private equity firm: Intermediate Capital Group acquisitions.
Fund returns
| Fund | Vintage | Size | Net IRR | TVPI | DPI | As of |
|---|---|---|---|---|---|---|
| ICG Europe Fund IX SCSp | 2025 | — | — | 1.35x | — | Sep 30, 2025 |
| ICG Centre Street Partnership, L.P. - Series N | 2024 | — | 8.8% | 1.06x | 0.15x | Sep 30, 2025 |
| ICG Centre Street Partnership, L.P. - Series S | 2024 | — | 6.2% | 1.05x | 0.26x | Sep 30, 2025 |
| ICG Global Co-Investment | 2024 | — | — | 1.00x | — | Dec 31, 2024 |
| ICG Global Loan Fund | 2024 | — | — | 1.10x | — | Dec 31, 2024 |
| ICG Global Total Credit Fund | 2024 | — | — | 1.10x | — | Dec 31, 2024 |
| ICG Strategic Equity Co-Investment Fund V-A | 2024 | — | — | 1.66x | 1.66x | Jun 30, 2025 |
| ICG Strategic Equity Fund V (USD) | 2024 | — | — | 1.48x | 0.00x | Jun 30, 2025 |
| ICG Strategic Equity Fund V (USD) V-A | 2024 | — | — | 1.49x | — | Jun 30, 2025 |
| ICG Europe Mid-Market Fund II SCSp | 2023 | — | — | 1.17x | — | Sep 30, 2025 |
| ICG North American Credit Partners III, L.P. | 2023 | — | — | 1.00x | 0.10x | Dec 31, 2024 |
| ICG Strategic Equity Fund V | 2023 | — | — | 1.49x | 0.00x | Jun 30, 2025 |
| ICG Europe Fund VIII SCSp | 2022 | — | 8.0% | 1.10x | 0.10x | Dec 31, 2024 |
| ICG Europe Fund VIII Feeder SCSp | 2021 | — | 22.9% | 1.41x | 0.15x | Sep 30, 2025 |
| ICG Exelsior SCSp | 2021 | — | — | 1.20x | 0.08x | Mar 31, 2025 |
| ICG Strategic Equity Co-Investment Fund IV | 2021 | — | 5.4% | 1.18x | — | Jun 30, 2025 |
| ICG Strategic Equity Fund IV | 2021 | — | 14.5% | 1.35x | 0.28x | Jun 30, 2025 |
| ICG Europe Mid-Market Fund | 2020 | — | 18.7% | 1.50x | 0.72x | Mar 31, 2025 |
| ICG North American Private Debt Fund II | 2019 | — | 10.0% | 1.20x | 0.83x | Mar 31, 2025 |
| ICG Europe Fund VII | 2018 | — | 14.3% | 1.60x | 0.73x | Mar 31, 2025 |
| ICG Europe Fund VII Feeder SCSp | 2018 | — | 14.6% | 1.64x | 1.24x | Sep 30, 2025 |
| ICG Strategic Equity Fund III LP | 2018 | — | 24.5% | 2.12x | 1.11x | Jun 30, 2025 |
| ICG Europe Fund VI, L.P. | 2015 | — | 19.5% | 1.82x | 1.75x | Sep 30, 2025 |
| ICG Europe Fund V, L.P. | 2011 | — | 7.9% | 1.29x | 1.24x | Sep 30, 2025 |
| ICG CENTRE ST PARTNERSHIP | — | — | — | 1.14x | — | Jun 30, 2024 |
| ICG STRATEGIC EQUITY COINV III | — | — | — | 2.34x | — | Jun 30, 2024 |
| ICG STRATEGIC EQUITY COINV IV | — | — | — | 1.11x | — | Jun 30, 2024 |
| ICG STRATEGIC EQUITY COINV V | — | — | — | 1.00x | — | Jun 30, 2024 |
Net returns as reported by the public-pension and foundation LPs invested in each fund.
Firm profile and fund returns: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
What Intermediate Capital Group invests in
- Health and bio · 2 · 100%
How Intermediate Capital Group invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Seed | 1 100% | $140M |
Share is of the 1 round on Recent Funding that name Intermediate Capital Group. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Intermediate Capital Group portfolio companies
DDraig Therapeutics$140MSeed · Jun 2025
GGrey Wolf Therapeuticsbacker
| Company | Round with Intermediate Capital Group | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Seed · $140M · lead | $205M | Jul 14, 2026 Series B+ |
Health and bio |
backer | $99M | May 23, 2024 Series B+ |
Most frequent co-investors
Similar investors
NNextech Invest2 companies · 3 deals in 12 mo
TThe Column Group2 companies · 3 deals in 12 mo
BBain Capital Life Sciences2 companies · 2 deals in 12 mo
CCalm/Storm VC2 companies · 2 deals in 12 mo
GGoHub Ventures2 companies · 2 deals in 12 mo
HHuatai Zijin Investment2 companies · 2 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
Portfolio companies are the companies on Recent Funding with a round that lists Intermediate Capital Group, which is a subset of its real portfolio. API: /api/v1/investors/intermediate-capital-group (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy